Therapy (HBV)
Thymosin (alpha)1 Shows Promise in Randomized Trial
Published in Hepatitis Weekly, May 18th, 1998
The Taiwanese study found that 40 percent of hepatitis B virus (HBV) infected patients treated with the immune modifier became hepatitis Be antigen (HBeAg) negative and HBV DNA seronegative one year after the end of therapy ("Efficacy of Thymosin (alpha)1 in Patients with Chronic Hepatitis B: A Randomized, Controlled Trial," Hepatology, May 1998;27(5):1383-1387).
Over the past 20 years, many antiviral or immunomodulatory agents, or both, have been used in patients with chronic HBV infection. ...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (1998-05-18)
More Articles from Hepatitis Weekly
- Transplantation (HBV)
HBV Transmission Possible from Organs Appearing to Have Past Infection - Disease Progression (HCV)
HCV+ Patients With Normal ALT Have Slow Progression to Fibrosis - Testing (HCV)
Risk Factor Questionnaire is Cost Effective Screening Method - Transmission (HCV)
Study Offers Evidence for Sexual Transmission - Adverse Effects (HCV Therapy)
HCV Patients Receiving Interferon alpha Treatment Are Susceptible to Depression - Blood Banking (Viral Inactivation)
Newly Licensed SD Plasma Product Inactivates Enveloped Viruses - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
